Life Sciences and Healthcare Consulting Services

Improving patient lives by helping clients discover, develop and bring new treatments and devices to market.

Talk to our experts
Life Sciences and Healthcare Consulting Services

Our passion is to partner with clients to achieve their strategic goals in delivering safe, effective and commercially successful treatments to patients faster. Throughout the Biopharma and MedTech product lifecycle, Clarivate consultants provide end-to-end solutions and transformative intelligence, using AI-enabled platforms and industry-leading products like Cortellis and Real World Data. Our teams fuel innovation in Research and Development, Commercial Strategy, Evidence and Value, Technology and are right by your side as you improve patient lives and create a healthier tomorrow. We advance the development and rollout of novel products that have a material impact on our customers’ performance. We believe human ingenuity can transform the world and improve our future.

A-Z project coverage from R&D to Commercialization

0 +

highly skilled consultants & analysts worldwide

0 +

years track record as a transformational, trusted industry partner

0 %

of world's top 50 pharma organization use our expertise

Ask our experts

Our Life Sciences and Healthcare consultants provide strategic guidance, professional services, custom data and technology enablement across the healthcare ecosystem. Meet some of our practice leaders

Kimon Kotronis

Director​ Technology Consulting

Sophie Doran

Senior Director Value Communication

Rick Finch

Global Lead Clarivate Consulting Services

Cliff Li

Partner - Market Access & Commercial Strategy Consulting

Mansoor Mukadam

Director - Commercial Strategy

Richard Massey

Associate Director - Value Communication

Anna Somuyiwa

Head of the Centre for Innovation in Regulatory Science

Regina Galera

Director - Regulatory and Clinical Consulting, Life Sciences and Healthcare

Sonam Dubey

Senior Director - Technology Consulting

Mausam Deb

Senior Director - Technology Consulting

Darrin Baines

Global Head of Health Economics

Ruth Howells

Senior Director - Health Technology Assessment

Laurie Dimodica

Senior Director - Global Access Advisory Services

Eric Persoff

Partner - Head of Japan and APAC - Commercial Strategy Consulting

Oliver Leatham

Partner - Commercial Strategy Consulting

Ken Walsh

Partner - Commercial Strategy Consulting

John Lebbos

Partner - Commercial Strategy Consulting

Jasmin Mehta

Senior Manager - Centre for Medicines Research

Alexander Ishkin

Senior Science Analyst Bioinformatics Services

Tatiana Kikalova​

Senior Manager - Data Science

John Stahl​

Partner​ US Pricing and Market Access​

Scott Tatro

Vice President​ Technology Consulting​

Helen Kitchen

Senior Director - Clinical Outcomes Assessment

Sunita Nair

Senior Director - Systematic Literature Reviews and Meta-analysis

Research and
development

We help companies advance their drug discovery, preclinical proof-of-concept, and regulatory activities. Clarivate’s translational science expertise, skilled teams of regulatory and commercial experts and assets such as the Centre for Medicine Research (CMR) combine to offer a highly reputable source of pharmaceutical industry metrics and insights. By providing perspective, data and insights across the development spectrum, we complement client teams in generating long term value.

Commercial strategy

Our deep domain expertise and data-driven analysis provides customized, actionable solutions for our clients in the areas of new product planning, portfolio strategy, pricing, and market access. Leveraging Clarivate proprietary data, real world evidence and deep consulting expertise we can help you make faster, more informed strategic decisions on your toughest challenges and most significant opportunities.

Evidence, value, and access

We provide integrated health economics and outcomes research, value communications, and real world evidence strategy to the life science industry, partnering with client teams over the lifecycle of a brand. Our team consists of technical experts including health economists, statisticians, medical writers, in-house graphic designers, commercial assessment analysts, systematic reviewers, and COA specialists, enabling us to provide bespoke, end-to-end solutions across the product lifecycle.

Technology

We offer highly customized, use-case-specific data deliveries including bespoke databases, data files, and workflow solutions built to exact specifications. Innovative solutions such as the Clarivate Regulatory Intelligence Tracker (a companion of Cortellis Regulatory Intelligence) provide decision support to key business leaders leveraging internal and external data assets. Our team of experts and their proven methodologies create unique tools that allow clients to make data-driven decisions with speed and certainty across the drug/device development lifecycle.

“The fundamentals underpinning the biopharma sector have never been stronger, with new technologies fueling medical advancements and providing treatment options to patients with previously unmet needs. Leveraging deep industry expertise and comprehensive therapeutic area differentiated data, this year’s Drugs to Watch report identifies innovative medicines based on recent scientific breakthroughs poised to have extraordinary impacts on patient outcomes.”​

Mike Ward, Global Head of Thought Leadership, Life Sciences and Healthcare

REPORT

What sets the Drugs to Watch in 2024 apart

From CRISPR to bispecifics, cancer to COPD, new drugs on the cusp

Our latest thought leadership

Let's talk

Learn how Clarivate consultants can provide the insight and foresight across your drug and device lifecycle.

Get in touch